Pembrolizumab held advanced head and neck cancers in a group of patients at bay for around two years.
from BBC News - Home https://ift.tt/2XIKkVh
Friday, November 22, 2019
Home »
bbc
,
BBC News - Home
,
bbclive
,
latest news
,
news
,
world news
» Cancer immunotherapy drug 'less toxic and prolongs life'






0 comments:
Post a Comment